Michael J. Rider - 02 Jan 2025 Form 4 Insider Report for RESMED INC (RMD)

Signature
Michael J. Rider, Global General Counsel and Secretary
Issuer symbol
RMD
Transactions as of
02 Jan 2025
Net transactions value
-$17,324
Form type
4
Filing time
03 Jan 2025, 16:52:14 UTC
Previous filing
02 Dec 2024
Next filing
04 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $17,324 -75 -0.82% $230.99 9,038 02 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024.